236
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series

, , , , , , , , , , , , , , , , , , , , , , & show all
Pages 812-819 | Received 26 Aug 2011, Accepted 18 Oct 2011, Published online: 31 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruben Fernandez-Alvarez, Ana P. Gonzalez-Rodriguez, M. Esther Gonzalez, Arturo Rubio-Castro, Francisco Dominguez-Iglesias, Jackeline Solano, Eva Alonso-Nogues, Carmen Fernandez-Alvarez, Yahya Zanabili, Jose Manuel Alonso, Angel Ramirez Payer, Jose Maria Vicente, Jesus Medina & Juan M. Sancho. (2015) Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy. Leukemia & Lymphoma 56:11, pages 3096-3102.
Read now

Articles from other publishers (12)

Chieh-Lin Jerry Teng, Tran-Der Tan, Yun-Yi Pan, Yu-Wen Lin, Pei-Wen Lien, Hsin-Chun Chou, Peng-Hsu Chen & Fang-Ju Lin. (2022) Prognostic Factors for Clinical Outcomes in Patients with Newly Diagnosed Advanced-stage Hodgkin Lymphoma: A Nationwide Retrospective Study. Cancer Control 29, pages 107327482211248.
Crossref
Semra Paydas, Sahin Laçin, Mutlu Doğan, Ibrahim Barista, Birol Yildiz, Gulsah Seydaoglu, Nuri Karadurmus, Sinem Civriz, Muhammed Ali Kaplan, Munci Yagci, Emel Gurkan & Vehbi Ercolak. (2021) IPS-3 Validation in 1012 cases with classical hodgkin lymphoma. Leukemia Research 102, pages 106519.
Crossref
John V. Asimakopoulos, Maria K. Angelopoulou, Maria‐Panagiota Arapaki, Alexandros Kanellopoulos, Maria Dimou, Xanthoula Giakoumis, Eliana Konstantinou, Marina Belia, Chrysovalantou Chatzidimitriou, Sotirios Sachanas, Theodoros Iliakis, Marie‐Christine Kyrtsonis, Marina P. Siakantaris, Nora‐Athina Viniou, Eleni Variamis, Flora N. Kontopidou, Gerassimos A. Pangalis, Panayiotis Panayiotidis, Kostas Konstantopoulos & Theodoros P. Vassilakopoulos. (2020) Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced‐stage Hodgkin‐lymphoma. British Journal of Haematology 190:6.
Crossref
Ron Daniel Jachimowicz, Luise Pieper, Sarah Reinke, Artur Gontarewicz, Annette Plütschow, Heinz Haverkamp, Leonie Frauenfeld, Falko Fend, Mathis Overkamp, Franziska Jochims, Christoph Thorns, Martin Leo Hansmann, Peter Möller, Andreas Rosenwald, Harald Stein, Hans Christian Reinhardt, Peter Borchmann, Bastian von Tresckow, Andreas Engert & Wolfram Klapper. (2020) Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica 106:6, pages 1684-1692.
Crossref
. 2018. Diagnostic Pathology: Blood and Bone Marrow. Diagnostic Pathology: Blood and Bone Marrow 878 883 .
José Carlos Jaime-Pérez, Carmen Magdalena Gamboa-Alonso, José Ramón Padilla-Medina, Raúl Alberto Jiménez-Castillo, Leticia Alejandra Olguín-Ramírez, César Homero Gutiérrez-Aguirre, Olga Graciela Cantú-Rodríguez & David Gómez-Almaguer. (2017) High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center. Revista Brasileira de Hematologia e Hemoterapia 39:4, pages 325-330.
Crossref
Pablo Guisado-Vasco, Carlos Montalban & Juan F. García. (2017) Comments on the value International Prognostic Score (IPS), stage IV and age over 45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group. British Journal of Haematology 178:2, pages 336-338.
Crossref
Theodoros P. Vassilakopoulos & Peter W.M. Johnson. (2016) Treatment of advanced-stage Hodgkin lymphoma. Seminars in Hematology 53:3, pages 171-179.
Crossref
Beatriz Sánchez-Espiridión, Ana M. Martín-Moreno, Carlos Montalbán, Vianihuini Figueroa, Francisco Vega, Anas Younes, L. Jeffrey Medeiros, Francisco J. Alvés, Miguel Canales, Mónica Estévez, Javier Menarguez, Pilar Sabín, María C. Ruiz-Marcellán, Andrés Lopez, Pedro Sánchez-Godoy, Fernando Burgos, Carlos Santonja, José L. López, Miguel A. Piris & Juan F. Garcia. (2013) MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma. British Journal of Haematology 162:3, pages 336-347.
Crossref
David W. ScottFong Chun ChanFangxin HongSanja RogicKing L. TanBarbara MeissnerSusana Ben-NeriahMerrill BoyleRobert KridelAdele TeleniusBruce W. WoolcockPedro FarinhaRichard I. FisherLisa M. RimszaNancy L. BartlettBruce D. ChesonLois E. ShepherdRanjana H. AdvaniJoseph M. ConnorsBrad S. KahlLeo I. GordonSandra J. HorningChristian SteidlRandy D. Gascoyne. (2013) Gene Expression–Based Model Using Formalin-Fixed Paraffin-Embedded Biopsies Predicts Overall Survival in Advanced-Stage Classical Hodgkin Lymphoma. Journal of Clinical Oncology 31:6, pages 692-700.
Crossref
Theodoros P. Vassilakopoulos & Maria K. Angelopoulou. (2013) Advanced and Relapsed/Refractory Hodgkin Lymphoma: What Has Been Achieved During the Last 50 Years. Seminars in Hematology 50:1, pages 4-14.
Crossref
King L. TanDavid W. ScottFangxin HongBrad S. KahlRichard I. FisherNancy L. BartlettRanjana H. AdvaniRena BucksteinLisa M. RimszaJoseph M. ConnorsChristian SteidlLeo I. Gordon, Sandra J. Horning & Randy D. Gascoyne. (2012) Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial. Blood 120:16, pages 3280-3287.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.